Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Thurs Jan 9th, the US Stock Markets will be closed in observance of a national day of mourning for former President Jimmy Carter. Read the press release here. Regular trading hours will resume tomorrow.

Altimmune Inc (ALT)

Altimmune Inc (ALT)
7.45 +0.14 (+1.92%) 01/08/25 [NASDAQ]
7.45 x 4,600 7.49 x 3,300
Realtime by (Cboe BZX)
7.45 x 4,600 7.49 x 3,300
Realtime 7.49 +0.04 (+0.54%) 01/08/25
Profile for Wed, Jan 8th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Altimmune Inc 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 USA

www.altimmune.com Employees: 59 P: 240-654-1450

Description:

Altimmune, Inc. is a clinical-stage immunotherapeutics company. It focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of disease. The company's proprietary platform technologies consist of RespirVec and Densigen. Altimmune Inc., formerly known as Pharmathene Inc., is based in Gaithersburg, United States.

Key Statistics

Overview:

Market Capitalization, $K 529,881
Enterprise Value, $K 394,721
Shares Outstanding, K 71,125
Annual Sales, $ 430 K
Annual Net Income, $ -88,450 K
Last Quarter Sales, $ 10 K
Last Quarter Net Income, $ -22,850 K
EBIT, $ -99,510 K
EBITDA, $ -101,500 K
60-Month Beta 0.22
% of Insider Shareholders 4.10%
% of Institutional Shareholders 78.05%
Float, K 68,209
% Float 95.90%
Short Volume Ratio 0.33

Growth:

1-Year Return -34.59%
3-Year Return -4.97%
5-Year Return 304.89%
5-Year Revenue Growth -95.84%
5-Year Earnings Growth 90.03%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.32 on 11/12/24
Next Earnings Date N/A
Earnings Per Share ttm -1.34
EPS Growth vs. Prev Qtr 8.57%
EPS Growth vs. Prev Year 17.95%
Annual Dividend Yield 0.00%
Most Recent Dividend 2.910 on 02/06/17
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 09/14/18

ALT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -55.81%
Return-on-Assets % -50.60%
Profit Margin % -20,569.77%
Debt/Equity 0.00
Price/Sales 9,716.57
Price/Cash Flow N/A
Price/Book 3.90
Book Value/Share 1.88
Interest Coverage -2,210.25

ALT Dividends

Date Value
02/06/17 $2.9100
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Trading Volume: The most powerful technical indicator in the world